Glatiramyl 40 mg/ml, Injektionslösung in einer Fertigspritze

7680675260010 CH-67526 Injektionslösung
Glatiramyl 40 mg/ml, Injektionslösung in einer Fertigspritze
Glatiramyl 40 mg/ml, Injektionslösung in einer Fertigspritze
Glatiramyl 40 mg/ml, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
12
Selling units
12
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/04/2025
Patient information leaflet
Français
10/04/2025
Patient information leaflet
Italien
10/04/2025
Summary of Product Characteristics
Allemand
10/04/2025
Summary of Product Characteristics
Français
10/04/2025
Summary of Product Characteristics
Italien
10/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance WIZUS
(N/A)
36.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 578.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2020

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
67526
Drug name
Glatiramyl 40mg/ml, Injektionslösung in einer Fertigspritze
Galenic form
LSPA
ATC Code
L03AX13
Authorization status
Z
Dispensing category
B
First authorization
12/05/2020
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
GLATIRAMYL sol inj 40 mg/ml 12 ser pré 1 ml
Description (DE)
GLATIRAMYL Inj Lös 40 mg/ml 12 Fertspr 1 ml
Market launch
12/05/2020
Narcotic (BTM)
No

Original drug

Copaxone, Injektionslösung in einer Fertigspritze
GTIN: 7680563630024
CHF 855.90
View original